Dosage forms and related therapies
First Claim
Patent Images
1. A composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a succinic acid addition salt of triethylenetetramine.
2 Assignments
0 Petitions
Accused Products
Abstract
This invention is directed in part to novel doses, dosage formulations, and routes of administration of such doses and dose formulations, said dose and dose formulations containing one or more copper chelators, for example, one or more trientine active agents, including trientine analogs, trientine salts, trientine prodrugs, and trientine derivatives, useful in the treatment of diseases, disorders and conditions, including in indications where copper may play a role.
-
Citations
18 Claims
- 1. A composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a succinic acid addition salt of triethylenetetramine.
Specification